NASDAQ:CERE
Delisted

Cerevel Therapeutics Holdings Stock Forecast

etoro logo Buy CERE
*Your capital is at risk
$44.96
+0 (+0%)
At Close: Oct 30, 2024

CERE Performance

FAQ

What is the symbol for Cerevel Therapeutics Holdings, Inc. Stock and on which exchange is it traded?
The symbol for Cerevel Therapeutics Holdings, Inc. is CERE and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Cerevel Therapeutics Holdings, Inc. Stock?
Cerevel Therapeutics Holdings, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Cerevel Therapeutics Holdings, Inc. Stock?
Cerevel Therapeutics Holdings, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cerevel Therapeutics Holdings, Inc. Stock.

What's the current price of Cerevel Therapeutics Holdings, Inc. Stock?
As of the end of day on the Oct 30, 2024, the price of an Cerevel Therapeutics Holdings, Inc. (CERE) share was $44.96.

What is the 52-week high and low for Cerevel Therapeutics Holdings, Inc. Stock?
The 52-week high for Cerevel Therapeutics Holdings, Inc. Stock is $44.99 and the 52-week low is $22.27.

What is the market capitalization of Cerevel Therapeutics Holdings, Inc. Stock?
As of the Oct 30, 2024, the market capitalization of Cerevel Therapeutics Holdings, Inc. is 8.191B.
Click to get the best stock tips daily for free!
ABOUT CEREVEL THERAPEUTICS HOLDINGS, INC.
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-concept trial in patients with drug-resistant focal onset seizures in epilepsy or focal epilepsy, as we...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.76% Jun 12
DHI
$146.71
7.57% Jun 10
PHM
$118.49
7.15% Jun 10
EAT
$140.46
17.39% Jun 05
TPR
$140.47
2.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE